Shares of Genpact Limited (NYSE:G - Get Free Report) have earned a consensus recommendation of "Hold" from the seven analysts that are covering the stock, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $52.2857.
G has been the subject of several recent analyst reports. Robert W. Baird lowered their price target on Genpact from $56.00 to $50.00 and set a "neutral" rating for the company in a report on Thursday, May 8th. Mizuho lifted their price target on Genpact from $48.00 to $51.00 and gave the company a "neutral" rating in a report on Tuesday, July 1st. Wall Street Zen upgraded Genpact from a "buy" rating to a "strong-buy" rating in a report on Friday, June 6th. Deutsche Bank Aktiengesellschaft initiated coverage on Genpact in a report on Thursday, July 17th. They issued a "hold" rating and a $47.00 price target for the company. Finally, JPMorgan Chase & Co. lowered their price target on Genpact from $55.00 to $50.00 and set a "neutral" rating for the company in a report on Wednesday.
Read Our Latest Research Report on Genpact
Genpact Price Performance
G stock traded up $0.8060 during trading on Wednesday, hitting $45.3260. The stock had a trading volume of 1,741,591 shares, compared to its average volume of 2,045,791. The company's 50 day moving average price is $44.06 and its two-hundred day moving average price is $46.83. Genpact has a 1-year low of $37.82 and a 1-year high of $56.76. The stock has a market cap of $7.90 billion, a price-to-earnings ratio of 15.06, a price-to-earnings-growth ratio of 1.56 and a beta of 0.92. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.53 and a current ratio of 1.53.
Genpact (NYSE:G - Get Free Report) last announced its earnings results on Thursday, August 7th. The business services provider reported $0.88 earnings per share for the quarter, beating the consensus estimate of $0.85 by $0.03. Genpact had a net margin of 10.92% and a return on equity of 22.15%. The firm had revenue of $1.25 billion during the quarter, compared to the consensus estimate of $1.23 billion. During the same quarter in the previous year, the company posted $0.79 EPS. The firm's revenue for the quarter was up 6.6% on a year-over-year basis. Genpact has set its FY 2025 guidance at 3.510-3.580 EPS. Q3 2025 guidance at 0.890-0.900 EPS. On average, sell-side analysts forecast that Genpact will post 3.21 EPS for the current fiscal year.
Genpact Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Thursday, September 11th will be issued a $0.17 dividend. The ex-dividend date is Thursday, September 11th. This represents a $0.68 annualized dividend and a yield of 1.5%. Genpact's payout ratio is 22.59%.
Hedge Funds Weigh In On Genpact
Several hedge funds and other institutional investors have recently modified their holdings of the company. JPMorgan Chase & Co. lifted its stake in shares of Genpact by 20.9% in the 1st quarter. JPMorgan Chase & Co. now owns 4,111,340 shares of the business services provider's stock valued at $207,129,000 after purchasing an additional 710,704 shares in the last quarter. Dimensional Fund Advisors LP lifted its stake in shares of Genpact by 5.7% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,848,449 shares of the business services provider's stock valued at $165,288,000 after purchasing an additional 208,759 shares in the last quarter. Geode Capital Management LLC lifted its stake in shares of Genpact by 2.5% in the 2nd quarter. Geode Capital Management LLC now owns 3,645,967 shares of the business services provider's stock valued at $160,480,000 after purchasing an additional 90,541 shares in the last quarter. Alliancebernstein L.P. lifted its stake in shares of Genpact by 4.1% in the 1st quarter. Alliancebernstein L.P. now owns 3,045,542 shares of the business services provider's stock valued at $153,434,000 after purchasing an additional 118,689 shares in the last quarter. Finally, Nordea Investment Management AB lifted its stake in shares of Genpact by 60.2% in the 2nd quarter. Nordea Investment Management AB now owns 2,617,255 shares of the business services provider's stock valued at $114,924,000 after purchasing an additional 983,774 shares in the last quarter. 96.03% of the stock is owned by institutional investors and hedge funds.
About Genpact
(
Get Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Further Reading

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.